Likewise, expression profile analysis using the newly developed tumor map strategy [119] (https://tumormap.ucsc.edu/) indicates that agrin may be expressed in a wide variety of cancers, closely matching the profile of YAP/TAZ (Figure 6A). This evidence concerns the gene YAP1 and neoplasm.